{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T22:10:49Z","timestamp":1765404649751,"version":"3.46.0"},"reference-count":25,"publisher":"BMJ","issue":"6440","license":[{"start":{"date-parts":[[1984,8,4]],"date-time":"1984-08-04T00:00:00Z","timestamp":460425600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br Med J (Clin Res Ed)"],"published-print":{"date-parts":[[1984,8,4]]},"abstract":"<jats:p>Most patients with Wilson's disease are treated with the potentially toxic cupriuretic agent penicillamine. The toxicity of zinc taken by mouth is low, and long term administration induces a negative copper balance. Two patients with severe neurological symptoms were given zinc sulphate by mouth three times daily in doses of 200 mg, later increased to 300 mg. One patient, a 21 year old man, started to receive zinc sulphate after his condition had deteriorated during treatment with cupriuretic drugs. The other, a 27 year old woman, was treated from the start with zinc sulphate. The conditions of both patients improved appreciably, and they were still receiving treatment with zinc sulphate roughly two years later. Effective depletion of body copper stores was shown by an intravenous radiocopper loading test and liver biopsy. No side effects were found. Wilson's disease may effectively be treated with zinc sulphate alone.<\/jats:p>","DOI":"10.1136\/bmj.289.6440.273","type":"journal-article","created":{"date-parts":[[2009,4,2]],"date-time":"2009-04-02T11:00:59Z","timestamp":1238670059000},"page":"273-276","source":"Crossref","is-referenced-by-count":50,"title":["Effective treatment of Wilson's disease with oral zinc sulphate: two case reports."],"prefix":"10.1136","volume":"289","author":[{"given":"T U","family":"Hoogenraad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C J","family":"Van den Hamer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Van Hattum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1984,8,4]]},"reference":[{"key":"ref_1","first-page":"1098","article-title":"Hereditary disorders of copper metabolism","volume-title":"The metabolic basis of inherited disease","author":"Sass-Kortsak, A.; Bearn, A.G.","year":"1978","unstructured":"Sass-Kortsak A, Bearn AG. Hereditary disorders of copper metabolism. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, eds. The metabolic basis of inherited disease. New York: McGraw-Hill, 1978:1098-260."},{"key":"ref_2","first-page":"487","article-title":"Penicillamine, a new oral therapy for Wilson's disease. Am 3 Med","volume":"21","author":"Walshe, J.M.","year":"1956","unstructured":"Walshe JM. Penicillamine, a new oral therapy for Wilson's disease. Am 3 Med 1956;21:487-95."},{"issue":"8","key":"ref_3","first-page":"155","volume":"1981","author":"Rheumatol","unstructured":"Rheumatol 1981;8, suppl 7: 155-60."},{"key":"ref_4","first-page":"379","article-title":"Wilson's disease (hepatolenticular degeneration)","volume-title":"Handbook of clinical neurology. Vol 27. Metabolic and deficiency diseases of the nervous system. Part I","author":"Walshe, J.M.","year":"1976","unstructured":"Walshe JM. Wilson's disease (hepatolenticular degeneration). In: Vinken PJ, Bruyn GW, Klawans HL, eds. Handbook of clinical neurology. Vol 27. Metabolic and deficiency diseases of the nervous system. Part I. Amsterdam: North Holland Publishing Company, 1976:379-414."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0140-6736(82)92201-2","article-title":"Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride","volume":"i:","author":"Walshe, J.M.","year":"1982","unstructured":"Walshe JM. Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride. Lancet 1982;i:643-7.","journal-title":"Lancet"},{"key":"ref_6","first-page":"1573","article-title":"Zur Vertraglichkeit von hochdosiertem peroralem","volume":"111","author":"Tschumi, P.; Floersheim, G.L.","year":"1981","unstructured":"Tschumi P, Floersheim GL. Zur Vertraglichkeit von hochdosiertem peroralem Zinksulfat. Schweiz Med Wochenschr 1981;111:1573-7.","journal-title":"Zinksulfat. Schweiz Med Wochenschr"},{"key":"ref_7","article-title":"De hepato-cerebrale degeneratie (met een onderzoek naar de zinkstofwisseling)","author":"Schouwink, G.","year":"1961","unstructured":"Schouwink G. De hepato-cerebrale degeneratie (met een onderzoek naar de zinkstofwisseling). Amsterdam: University of Amsterdam, 1961. Thesis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000115077","article-title":"Oral zinc sulphate as long term treatment in Wilson's disease (hepatolenticular degeneration)","volume":"18","author":"RHoogenraad, T.U.; Koevoet, R.; de Ruyter Korver, E.G.W.M.","year":"1979","unstructured":"RHoogenraad TU, Koevoet R, de Ruyter Korver EGWM. Oral zinc sulphate as long term treatment in Wilson's disease (hepatolenticular degeneration). Eur Neurol 1979;18:205-11.","journal-title":"Eur Neurol"},{"key":"ref_9","first-page":"1262","article-title":"Ruyter Korver EGWM Oral zinc in Wilson's disease","volume":"ii:","author":"Hoogenraad, T.U.; Van den Hamer, C.J.A.; Koevoet, R.; de","year":"1978","unstructured":"Hoogenraad TU, Van den Hamer CJA, Koevoet R, de Ruyter Korver EGWM Oral zinc in Wilson's disease. Lancet 1978;ii:1262.","journal-title":"Lancet"},{"key":"ref_10","first-page":"87","article-title":"De behandeling van koperstapeling met oraal zink","volume-title":"en galwegen 1981","author":"Hoogenraad, T.U.","year":"1981","unstructured":"Hoogenraad TU. De behandeling van koperstapeling met oraal zink. In: Van den Berg SG, Kater A, Soeters PB, eds. Lever en galwegen 1981. Utrecht\/Antwerp: Bohn, Scheltema, and Holkema, 1981:87-91."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1600-0404.1983.tb03153.x","article-title":"Three years of continuous oral zinc therapy in 4 patients with Wilson's disease","volume":"67","author":"Hoogenraad, T.U.; Van den Hamer, C.J.A.","year":"1983","unstructured":"Hoogenraad TU, Van den Hamer CJA. Three years of continuous oral zinc therapy in 4 patients with Wilson's disease. Acta Neurol Scand 1983;67:356-64.","journal-title":"Acta Neurol Scand"},{"issue":"335-8","key":"ref_12","first-page":"\"3Van\" # \"71","article-title":"Possible errors in sampling percutaneous liver biopsies for determination of trace element status: application to patients with primary biliary cirrhosis","volume":"113","author":"Nooijen, J.L.; Van den Hamer, C.J.A.; Houtman, J.P.W.; Schalm, S.W.","year":"1981","unstructured":"Nooijen JL, Van den Hamer CJA, Houtman JPW, Schalm SW. Possible errors in sampling percutaneous liver biopsies for determination of trace element status: application to patients with primary biliary cirrhosis. Clin Chem Acta 1981;113: 335-8. 3Van den Hamer CJA, Janssens AR, Hoogenraad TU. Onderzoek van de koperstofwisseling met 64Cu. Nucleair Geneeskundig Bulletin 1981;3:71-80.","journal-title":"Clin Chem Acta; Onderzoek van de koperstofwisseling met 64Cu"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1001\/archneur.1982.00510140063018","article-title":"Wilson's disease, report of a case in a Nigerian","volume":"39","author":"Longe, A.C.; Glew, R.H.; Omene, J.A.","year":"1982","unstructured":"Longe AC, Glew RH, Omene JA. Wilson's disease, report of a case in a Nigerian. Arch Neurol 1982;39:129-30.","journal-title":"Arch Neurol"},{"key":"ref_14","first-page":"\"49","article-title":"Metabolic interactions of copper with other trace elements. In: Biological roles of copper","volume":"6","author":"Mills, C.F.","year":"1980","unstructured":"Mills CF. Metabolic interactions of copper with other trace elements. In: Biological roles of copper. Amsterdam: Excerpta Medica, 1980:49-69. (Ciba Foundation Symposium No 79.) 6 Prasad AS, Brewer GJ, Schoomaker EB, Rabbani P. Hypocupremia induced by zinc therapy in adults. JAMA 1978;240:2166-8.","journal-title":"JAMA; Hypocupremia induced by zinc therapy in adults"},{"key":"ref_15","first-page":"79","article-title":"Effect of chronic zinc intoxication on copper levels, blood formation and polyamines","volume":"9","author":"Pfeiffer, C.C.; Papaioannou, R.; Rohler, A.","year":"1980","unstructured":"Pfeiffer CC, Papaioannou R, Rohler A. Effect of chronic zinc intoxication on copper levels, blood formation and polyamines. Journal of Orthomolecular Psychiatry 1980;9:79-89.","journal-title":"Journal of Orthomolecular Psychiatry"},{"key":"ref_16","article-title":"Du pronostic et du traitement de l'epilepsie","author":"Herpin, T.","year":"1852","unstructured":"Herpin T. Du pronostic et du traitement de l'epilepsie. Paris: Bailliere, 1852."},{"key":"ref_17","article-title":"Rational diagnosis and treatment","author":"Wulff, H.R.","year":"1976","unstructured":"Wulff HR. Rational diagnosis and treatment. Oxford: Blackwell Scientific Publications, 1976."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1056\/NEJM198211183072110","article-title":"Historical controls; the practitioner's clinical trials","volume":"307","author":"Lasagna, L.","year":"1982","unstructured":"Lasagna L. Historical controls; the practitioner's clinical trials. N Engl J Med 1982;307:1339-40.","journal-title":"N Engl J Med"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"314","DOI":"10.7326\/0003-4819-99-3-314","article-title":"Oral zinc therapy for Wilson's disease","volume":"99","author":"Brewer, G.J.; Hill, G.M.; Prasad, A.S.; Cossack, Z.T.; Rabbani, P.","year":"1983","unstructured":"Brewer GJ, Hill GM, Prasad AS, Cossack ZT, Rabbani P. Oral zinc therapy for Wilson's disease. Ann Intern Med 1983;99:314-20.","journal-title":"Ann Intern Med"},{"article-title":"64Cu-loading tests for monitoring zinc therapy in Wilson's disease. Trace Elements in Medicine","author":"den Hamer CJA, Van; TU, Hoogenraad","key":"ref_20","unstructured":"Van den Hamer CJA, Hoogenraad TU. 64Cu-loading tests for monitoring zinc therapy in Wilson's disease. Trace Elements in Medicine (in press)."},{"article-title":"Accepted","year":"1984","key":"ref_21","unstructured":"(Accepted 9 April 1984)"},{"key":"ref_22","article-title":"We examined the case notes of several hundred patients whose diagnosis at discharge from this hospital from January 1975 to","volume-title":"had included pulmonary embolism. Criteria for inclusion in the study were: (1) A firm clinical diagnosis of acute minor pulmonary embolism. This was defined as the sudden onset of dyspnoea-with or without cough, haemoptysis, or pleuritic chest pain-that could not be accounted for by any other mechanism on clinical and chest x ray examination","year":"1982","unstructured":"We examined the case notes of several hundred patients whose diagnosis at discharge from this hospital from January 1975 to August 1982 had included pulmonary embolism. Criteria for inclusion in the study were: (1) A firm clinical diagnosis of acute minor pulmonary embolism. This was defined as the sudden onset of dyspnoea-with or without cough, haemoptysis, or pleuritic chest pain-that could not be accounted for by any other mechanism on clinical and chest x ray examination."},{"key":"ref_23","unstructured":"No known pre-existing cardiovascular or respiratory disease.","article-title":"No known pre-existing cardiovascular or respiratory disease"},{"key":"ref_24","unstructured":"The presence on examination of tachypnoea and tachycardia.","article-title":"The presence on examination of tachypnoea and tachycardia"},{"key":"ref_25","unstructured":"Arterial blood gas tensions obtained within 24 hours of the lung scan and with the patient breathing room air.","article-title":"Arterial blood gas tensions obtained within 24 hours of the lung scan and with the patient breathing room air"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.289.6440.273","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.289.6440.273","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T22:05:52Z","timestamp":1765404352000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.289.6440.273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1984,8,4]]},"references-count":25,"journal-issue":{"issue":"6440","published-online":{"date-parts":[[1984,8,4]]},"published-print":{"date-parts":[[1984,8,4]]}},"alternative-id":["10.1136\/bmj.289.6440.273"],"URL":"https:\/\/doi.org\/10.1136\/bmj.289.6440.273","relation":{},"ISSN":["0007-1447","1468-5833"],"issn-type":[{"type":"print","value":"0007-1447"},{"type":"electronic","value":"1468-5833"}],"subject":[],"published":{"date-parts":[[1984,8,4]]}}}